Interferon-free hepatitis C treatment works for people on methadone or buprenorphine
AbbVie 3D regimen cures most genotype 1 HCV in people with HIV and HCV co-infection
Sofosbuvir + ribavirin cures hepatitis C for more than 80% of people with HIV and HCV co-infection
Low uptake of HCV treatment in England will lead to substantial disease burden by 2035
Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation
Sustained response to treatment reduces fatigue in hepatitis C patients
Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4
Sofosbuvir for hepatitis C works well despite multiple negative predictive factors
Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6
